Alfresa Pharma's management philosophy is “actively taking on the challenge of the new ‘Unmet Medical Needs’ of the times and contributing to people’s health and spiritual satisfaction in the broad areas of prevention, diagnosis, and treatment.”

In our corporate activities, we place the highest priority on human life and health, and we are committed to creating new value for the Alfresa Group as a whole through collaboration with Group companies, conducting trustworthy business activities with thorough compliance, creating an open corporate culture and an environment where employees can have pride and purpose in life, and realizing a sustainable society.

In April 2023, we merged with Sannova Co. Ltd., which also belongs to the Alfresa Group's manufacturing business segment, and began a new journey toward further growth. We will strive to expand our long-standing contract manufacturing business for pharmaceutical products and further strengthen our contract manufacturing capabilities to meet a variety of needs.

Furthermore, in order to play a part in the Alfresa Group's vision of “Realizing a Healthcare Consortium” that can provide products and services in all areas related to health, we will strive to research, develop and stably supply high-quality, high-value-added products based on reliable, safe, and sincere manufacturing.

We look forward to your continued support in the future.